Inactive Instrument

Analyst Reco. Bausch Health Companies Inc Toronto S.E.

Equities

CA91911K1021

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

RBC Trims Price Target on Bausch Health to $11 From $12, Keeps Sector Perform Rating	Apr. 23	MT
Bausch Health's Issuer Credit Rating Upgraded by S&P	Apr. 19	MT
Trump eyes $43 million haul from biggest fundraiser yet	Apr. 06	RE
RBC Ups PT on Bausch Health Companies to $12 From $9 Reflecting Upcoming Appellate Court Decisions & Potential BLCO Distribution, Maintains Sector Perform Rating	Apr. 05	MT
RBC Lifts Price Target on Bausch Health to $9 From $8, Keeps Sector Perform Rating	Feb. 23	MT
North American Morning Briefing : Mood Lifted on Hopes Rate-Hike Cycle Has Peaked	Nov. 02	DJ
RBC Cuts Price Target on Bausch Health to $8 From $9 Ahead of Q3 Report, Keeps Sector Perform Rating	23-10-23	MT
Fitch Affirms Bausch Health, Bausch Health America's Ratings; Bausch + Lomb's Rating Maintained	23-10-04	MT
Jefferies Upgrades Bausch Health to Buy From Hold, Adjusts Price Target to $16 From $9	23-09-20	MT
Moody's Rates Bausch + Lomb's New Secured Debt Instruments	23-09-12	MT
RBC Boosts Price Target on Bausch Health to $9 From $8 Ahead of Q2 Report, Maintains Sector Perform Rating	23-07-24	MT
TD Cowen Downgrades Bausch Health to Market Perform From Outperform, Adjusts Price Target to $12 From $35	23-06-16	MT
Jefferies Adjusts Price Target on Bausch Health to $9.50 From $7, Maintains Hold Rating	23-05-22	MT
RBC Cuts Price Target on Bausch Health to $8 From $9, Notes Concerns for Ability to Distribute Bausch + Lomb Shares, Keeps Sector Perform Rating	23-05-05	MT
Factbox-US government to impose inflation penalties on 27 drugs	23-03-15	RE
Bausch Health Price Target Raised to US$10 (From US$8), Market Perform Rating Maintained After "Solid Q4" and 2023 Guide	23-02-24	MT
RBC Lifts Price Target on Bausch Health to $9 From $8, Maintains Sector Perform Rating	23-02-24	MT
Fitch Lowers Bausch Health to RD; Upgrades to CCC Post Distressed Exchange; Also Downgrades Bausch + Lomb	22-10-07	MT
Fitch Downgrades Bausch Health to 'RD'; Upgrades to 'CCC' Post Distressed Exchange	22-10-07	AQ
Fitch Downgrades Bausch + Lomb's IDR to 'B-'; Evolving Rating Watch Pre and Post Downgrade	22-10-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Bausch Health Companies Inc Toronto S.E.

Equities

CA91911K1021

Analyst Reco.

Filters